Filing Flows › West Pharmaceutical Services (WST) › Operating margin
West Pharmaceutical Services (WST) operating margin by quarter
West Pharmaceutical Services' operating margin was 30.6% in Q3 2026 (third quarter 2026), +10.0 pts from Q2 2026. Over the last 7 quarters it ranged from 15.3% (Q1 2025) to 30.6% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 30.6% | +10.0 pts | +9.7 pts |
| Q2 2026 | 20.5% | -0.4 pts | +0.5 pts |
| Q1 2026 | 21.0% | +1.5 pts | +5.6 pts |
| Q4 2025 | 19.5% | -1.4 pts | — |
| Q3 2025 | 20.8% | +0.8 pts | — |
| Q2 2025 | 20.1% | +4.7 pts | — |
| Q1 2025 | 15.3% | — | — |
Q3 2026 at a glance
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
Questions
What is West Pharmaceutical Services' operating margin?
West Pharmaceutical Services' operating margin was 30.6% in Q3 2026 (third quarter 2026), +10.0 pts from Q2 2026.
How has West Pharmaceutical Services' operating margin changed?
Over the last 7 quarters it ranged from 15.3% (Q1 2025) to 30.6% (Q3 2026).
Q3 2026 results → · How West Pharmaceutical Services makes money →